Enzyme Regulation Flashcards
(29 cards)
Allosteric Regulation
- Importance of regulation in metabolic pathways
- Allostery
- ATCase and glycogen phosphorylase as example of allosteric regulation
- New approaches to allostery
Metabolic Pathways
- Life requires a complex set of chemical reactions
- Many metabolic pathways use the same starting materials
- Interconnected in many ways
- Regulation of the flux through these pathways is key to maintaining organisms health
Means to Regulate Metabolic Flux
- Control the amount of enzyme
- Transcriptional or translational control
- Control the activity of the enzymes present
Ways to modulate enzyme activity
- Allosteric Enzymes: modify activity with other molecules that enhance or inhibit activity
- Phosphorylation: Covalent Modification
- Zymogens: Convert inactive to active forms
- Tight Binding Proteins: Protein-Protein interactions to regulate enzyme activity
Allosteric Enzymes
- Usually larger symmetric multi-subunit enzymes
- Allosteric enzyme activities are regulated by small metabolites, which are substrates, activators, and inhibitors that bind to sites other than the active site
- Exists in 2 forms, active R state and less active T state
- Frequently exhibit cooperative binding of substrate to the active site
- Kinetics of the enzyme show a sigmoidal response to increased substrate concentration
Models of Allosteric Interactions - MWC Model
- Symmetry Model
- Each subunit exists in either the T or R state
- Ligand binds to either state
- Molecular symmetry of the oligomer is maintained
Models of Allosteric Interactions - KNF Model
- Sequential model, induced fit
- Ligand binding to one subunit changes the affinity for adjacent subunits
- As more ligands are bound, more subunits adopt high affinity conformation
Effector Molecules - Homotropic Effector
Substrate binds one subunit and increases affinity at another
Effector Molecules - Heterotropic Effector
Binds at sites other than the active site and are not substrate
Effects of Activators
- Stabilize the R state of the enzyme
- Activity is increased by increasing Vmax or decreasing Km
- Also tend to decrease cooperative binding of substrate
Effects of Inhibitors
- Inhibitors stabilize the T state of the enzyme
- Activity is decreased by decreasing Vmax or increasing Km
- Also increase cooperative binding of substrate
Asparate Transcarbamoylase
- A model allosteric enzyme that catalyzes the first commited step in pyrimidine biosynthesis
- Catalyzes the initial step in the synthesis of pyrimidines, Cytidine, Thymidine, and Uridine
Asparate Transcarbamoylase Mechanism
- Ordered binding of substrates
- Carbonyl Phosphate binds first
- Binding of CP causes changes in the local structure and creates the ASP binding site
- ASP binding cause both tertiary and quaternary structural changes
Cooperative Binding of Substrate
- The binding of aspartate is cooperative
- ATP is a + effector
- CTP is an inhibitor
- CTP and UTP are required for complete inhibition
Why are ATP, UTP, and CTP regulators of ATCase
- CTP and UTP are products of the pyrimidine pathway “feed back inhibition”
- ATP is a purine, which must be kept in balance for DNA and RNA synthesis
Structural Studies of the Synergy of CTP, UTP and Mg2+
Kinetic Experiments and new structures determined with careful controlled Mg2+ concentrations show that Mg2+ cations and UTP are required for full allosteric inhibition of ATCase
ATCase
- An allosteric enzyme regulated by feedback inhibition and feed forward activation to maintain the balance of the pyrimidine purine pools in diving cells
- The structural changes upon binding of substrate and effectors support the MWC model of allostery
Glycogen Phosphorylase
- Catalyzes the stepwise removal of glucose residues from the glucose storage molecule glycogen
Summary of Traditional Approach to Allostery
- Allosteric enzymes regulate the majority of metabolic pathways in the cell
- Homotropic allosteric effects lead to cooperative binding of substrate, allowing greater sensitivity to changes in substrate concentrations
- Heterotropic effectors, metabolites in the pathway, enhance or decrease enzyme activity in response to changes in the cellular requirements for the products of the pathway
Models of Allosteric Interactions
- Entropy driven, dynamic model
- No structural changes between active and inactive form
- Effector changes side chain or backbone dynamics of the protein
Changes in Protein Dynamics
- Dihydrodipicolinate synthase catalyzes the first committed step in the biosynthesis of lysine
- The tetrameric enzyme is allosterically inhibited by lysine
- No change in structure, just mobility
Ensemble Model of Allostery
- Protein exists as an ensemble of structures with different domains folded
- Effector binding changes the distribution of forms, increasing or decreasing the activity
Morpheein Model of Allostery
- Subunits arrange in different quaternary structures by dissociation and reassociation into a different oligomer
- One form is active and the other is not
- Porphobilinogen synthase
Medicinal Chemistry and Allostery
- Enzyme active sites are more conserved than allosteric sites
- Allosteric drugs can be more species specific